PT2553118E - Método para previsão da recorrência de cancro da mama em tratamento endócrino - Google Patents
Método para previsão da recorrência de cancro da mama em tratamento endócrino Download PDFInfo
- Publication number
- PT2553118E PT2553118E PT117105262T PT11710526T PT2553118E PT 2553118 E PT2553118 E PT 2553118E PT 117105262 T PT117105262 T PT 117105262T PT 11710526 T PT11710526 T PT 11710526T PT 2553118 E PT2553118 E PT 2553118E
- Authority
- PT
- Portugal
- Prior art keywords
- breast cancer
- cancer recurrence
- endocrine treatment
- prediction under
- recurrence prediction
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title 1
- 208000026310 Breast neoplasm Diseases 0.000 title 1
- 230000002124 endocrine Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10158561 | 2010-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2553118E true PT2553118E (pt) | 2014-12-17 |
Family
ID=43857901
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT117105262T PT2553118E (pt) | 2010-03-31 | 2011-03-29 | Método para previsão da recorrência de cancro da mama em tratamento endócrino |
| PT141887919T PT2845911T (pt) | 2010-03-31 | 2011-03-29 | Método para previsão da recorrência de cancro da mama em tratamento endócrino |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT141887919T PT2845911T (pt) | 2010-03-31 | 2011-03-29 | Método para previsão da recorrência de cancro da mama em tratamento endócrino |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US20130065786A1 (pt) |
| EP (2) | EP2553118B1 (pt) |
| JP (2) | JP5940517B2 (pt) |
| KR (1) | KR101864855B1 (pt) |
| CN (2) | CN105821125A (pt) |
| BR (2) | BR112012024718A2 (pt) |
| CA (1) | CA2793133C (pt) |
| ES (2) | ES2525382T3 (pt) |
| HK (1) | HK1181817A1 (pt) |
| HU (1) | HUE030164T2 (pt) |
| MX (1) | MX2012011167A (pt) |
| PL (2) | PL2553118T3 (pt) |
| PT (2) | PT2553118E (pt) |
| RU (1) | RU2654587C2 (pt) |
| UA (1) | UA110790C2 (pt) |
| WO (1) | WO2011120984A1 (pt) |
| ZA (1) | ZA201207229B (pt) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030198972A1 (en) | 2001-12-21 | 2003-10-23 | Erlander Mark G. | Grading of breast cancer |
| PT2553118E (pt) | 2010-03-31 | 2014-12-17 | Sividon Diagnostics Gmbh | Método para previsão da recorrência de cancro da mama em tratamento endócrino |
| ES2608322T3 (es) | 2011-07-28 | 2017-04-07 | Sividon Diagnostics Gmbh | Procedimiento para predecir la respuesta a la quimioterapia en un paciente que padece o está en riesgo de desarrollar cáncer de mama recurrente |
| SG11201402042PA (en) * | 2011-11-08 | 2014-06-27 | Genomic Health Inc | Method of predicting breast cancer prognosis |
| MX369628B (es) * | 2012-05-22 | 2019-11-14 | Nanostring Technologies Inc | Genes nano46 y metodos para predecir el resultado del cancer de mama. |
| WO2013188600A1 (en) * | 2012-06-12 | 2013-12-19 | Washington University | Copy number aberration driven endocrine response gene signature |
| WO2013190081A1 (en) * | 2012-06-22 | 2013-12-27 | Proyecto De Biomedicina Cima, S.L. | Methods and reagents for the prognosis of cancer |
| ES2654469T3 (es) | 2013-02-01 | 2018-02-13 | Sividon Diagnostics Gmbh | Procedimiento de predicción del beneficio de la inclusión de taxano en un régimen de quimioterapia en pacientes con cáncer de mama |
| JP2014236726A (ja) * | 2013-05-07 | 2014-12-18 | 独立行政法人国立がん研究センター | 胃がんの再発を予測する方法 |
| CA2912445A1 (en) * | 2013-05-13 | 2014-11-20 | Nanostring Technologies, Inc. | Methods to predict risk of recurrence in node-positive early breast cancer |
| WO2015015000A1 (en) * | 2013-08-02 | 2015-02-05 | Université Catholique de Louvain | Signature of cycling hypoxia and use thereof for the prognosis of cancer |
| WO2015038682A1 (en) * | 2013-09-11 | 2015-03-19 | bio Theranostics, Inc. | Predicting breast cancer recurrence |
| CN112522408A (zh) * | 2013-09-23 | 2021-03-19 | 芝加哥大学 | 关于dna损伤制剂用于癌症治疗的方法和组合物 |
| KR101548830B1 (ko) * | 2013-12-30 | 2015-08-31 | 가천대학교 산학협력단 | 줄기세포 배양방법을 이용하여 발굴된 유방암 줄기세포 마커를 이용한 유방암 예후 예측용 조성물 |
| EP3097421B1 (en) * | 2014-01-22 | 2019-11-13 | Koninklijke Philips N.V. | Improved stratification of patients for assessing the suitability of a therapy |
| RU2566732C1 (ru) * | 2014-07-08 | 2015-10-27 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт онкологии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИ онкологии" СО РАМН) | Способ прогнозирования лимфогенного метастазирования при инвазивной карциноме неспецифического типа молочной железы |
| CN104263815B (zh) * | 2014-08-25 | 2017-01-25 | 复旦大学附属肿瘤医院 | 一组用于激素受体阳性乳腺癌预后的基因及其应用 |
| WO2016092299A1 (en) * | 2014-12-09 | 2016-06-16 | Medical Research Council | Methods and kits for predicting the response to therapy of cancer |
| JP7144934B2 (ja) | 2015-03-25 | 2022-09-30 | ザ ジェネラル ホスピタル コーポレイション | 血液試料中の循環腫瘍細胞のデジタル分析 |
| CA3016677A1 (en) | 2016-03-09 | 2017-09-14 | Myriad International Gmbh | Method for determining the risk of recurrence of an estrogen receptor-positive and her2-negative primary mammary carcinoma under an endocrine therapy |
| CN109069602B (zh) * | 2016-04-14 | 2022-11-22 | 刘扶东 | 抑制scube2，一种新颖vegfr2辅助受体，抑制肿瘤血管发生 |
| CA3022377A1 (en) * | 2016-04-29 | 2017-11-02 | Board Of Regents, The University Of Texas System | Targeted measure of transcriptional activity related to hormone receptors |
| CN106480201A (zh) * | 2016-10-26 | 2017-03-08 | 北京鑫诺美迪基因检测技术有限公司 | 乳腺癌转移评估试剂盒 |
| EP3532642B1 (en) * | 2016-10-27 | 2021-12-08 | The General Hospital Corporation | Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancers |
| KR101950717B1 (ko) * | 2016-11-23 | 2019-02-21 | 주식회사 젠큐릭스 | 유방암 환자의 화학치료 유용성 예측 방법 |
| KR101896545B1 (ko) * | 2016-11-25 | 2018-09-07 | 주식회사 젠큐릭스 | 유방암 환자의 예후 예측 방법 |
| RU2671557C1 (ru) * | 2017-07-10 | 2018-11-02 | Александр Григорьевич Тоневицкий | Набор реагентов для определения риска возникновения рецидива онкологических заболеваний молочной железы |
| CA3075265A1 (en) * | 2017-09-08 | 2019-03-14 | Myriad Genetics, Inc. | Method of using biomarkers and clinical variables for predicting chemotherapy benefit |
| CN108441559B (zh) * | 2018-02-27 | 2021-01-05 | 海门善准生物科技有限公司 | 一种免疫相关基因群作为标志物在制备评估高增殖性乳腺癌远处转移风险的产品中的应用 |
| JP7199045B2 (ja) * | 2018-04-13 | 2023-01-05 | 国立大学法人大阪大学 | 乳癌の予後に関する情報の取得方法、乳癌の予後の判定装置及びコンピュータプログラム |
| CN108715804A (zh) * | 2018-05-14 | 2018-10-30 | 浙江大学 | 一种群智能寻优的肺癌癌细胞检测仪 |
| CN108424969B (zh) * | 2018-06-06 | 2022-07-15 | 深圳市颐康生物科技有限公司 | 一种生物标志物、诊断或预估死亡风险的方法 |
| JP2020028278A (ja) * | 2018-08-24 | 2020-02-27 | 国立大学法人九州大学 | 被検体に生じるイベントを予測するための判別器の生成方法、及び前記判別器を用いた被検体の層別化方法 |
| WO2020118245A1 (en) * | 2018-12-06 | 2020-06-11 | Georgia State University Research Foundation, Inc. | Quantitative centrosomal amplification score to predict local recurrence of ductal carcinoma in situ |
| KR20220044504A (ko) * | 2019-07-05 | 2022-04-08 | 인텔렉슨 게엠베하 | 개인 hla 패턴의 결정, 예후인자로서의 용도, 표적 유전자 및 치료제 |
| CN114830258A (zh) * | 2019-09-16 | 2022-07-29 | 斯坦福大学托管董事会 | 基于乳腺癌的分子表征的治疗方法 |
| KR102325945B1 (ko) * | 2020-04-22 | 2021-11-12 | 아주대학교산학협력단 | 두경부암 예후 예측용 바이오마커 조성물 |
| CN112852968A (zh) * | 2021-04-08 | 2021-05-28 | 杨文琳 | 基于免疫相关lncRNA构建三阴性乳腺癌风险预测方法 |
| CN114480652A (zh) * | 2022-02-21 | 2022-05-13 | 深圳市陆为生物技术有限公司 | 评价乳腺癌患者对于辅助内分泌治疗的响应性的产品 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6686446B2 (en) | 1998-03-19 | 2004-02-03 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| JP4277452B2 (ja) | 2000-02-25 | 2009-06-10 | ソニー株式会社 | 記録装置、再生装置 |
| EA006512B1 (ru) * | 2001-04-27 | 2005-12-29 | Институт молекулярной биологии им. В.А.Энгельгардта РАН | Способы анализа последовательностей нуклеиновых кислот с использованием биологического олигонуклеотидного микрочипа и наборы для их осуществления |
| US7297480B2 (en) | 2001-06-28 | 2007-11-20 | Dermtech International | Method for detection of melanoma |
| US20040002067A1 (en) | 2001-12-21 | 2004-01-01 | Erlander Mark G. | Breast cancer progression signatures |
| US20060024692A1 (en) * | 2002-09-30 | 2006-02-02 | Oncotherapy Science, Inc. | Method for diagnosing non-small cell lung cancers |
| FR2863275B1 (fr) * | 2003-12-09 | 2007-08-10 | Biomerieux Sa | Procede pour le diagnostic/pronostic du cancer du sein |
| EP1721159B1 (en) * | 2004-02-20 | 2014-12-10 | Janssen Diagnostics, LLC | Breast cancer prognostics |
| US20060063190A1 (en) * | 2004-09-22 | 2006-03-23 | Tripath Imaging, Inc | Methods and compositions for evaluating breast cancer prognosis |
| EP1815014B1 (en) | 2004-11-05 | 2012-03-21 | Genomic Health, Inc. | Molecular indicators of breast cancer prognosis and prediction of treatment response |
| CA2596640A1 (en) | 2005-02-04 | 2006-08-10 | Rosetta Inpharmatics Llc | Methods of predicting chemotherapy responsiveness in breast cancer patients |
| WO2006119593A1 (en) * | 2005-05-13 | 2006-11-16 | Universite Libre De Bruxelles | Gene-based algorithmic cancer prognosis |
| WO2006135886A2 (en) * | 2005-06-13 | 2006-12-21 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| CA2612021A1 (en) | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| GB0512299D0 (en) | 2005-06-16 | 2005-07-27 | Bayer Healthcare Ag | Diagnosis prognosis and prediction of recurrence of breast cancer |
| JP2009507496A (ja) * | 2005-09-09 | 2009-02-26 | ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム | エストロゲン受容体（ｅｒ）遺伝子およびｅｒ関連遺伝子のゲノム発現の算出された指標 |
| EP2041307A2 (en) * | 2006-07-13 | 2009-04-01 | Siemens Healthcare Diagnostics GmbH | Prediction of breast cancer response to taxane-based chemotherapy |
| WO2008046182A1 (en) * | 2006-09-15 | 2008-04-24 | Mcgill University | Stroma derived predictor of breast cancer |
| KR101475447B1 (ko) | 2006-12-01 | 2014-12-23 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 자기-조립 블록 코폴리머의 베시클 그리고 그것의 제조 및 사용 방법 |
| US9353415B2 (en) * | 2006-12-19 | 2016-05-31 | Thomson Reuters (Scientific) Llc | Methods for functional analysis of high-throughput experimental data and gene groups identified therefrom |
| ES2583377T3 (es) | 2007-06-08 | 2016-09-20 | Genentech, Inc. | Marcadores de expresión génica de la resistencia tumoral al tratamiento con inhibidor de HER2 |
| EP2036988A1 (en) | 2007-09-12 | 2009-03-18 | Siemens Healthcare Diagnostics GmbH | A method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent |
| WO2009095319A1 (en) | 2008-01-28 | 2009-08-06 | Siemens Healthcare Diagnostics Gmbh | Cancer prognosis by majority voting |
| WO2009114836A1 (en) | 2008-03-14 | 2009-09-17 | Genomic Health, Inc. | Gene expression markers for prediction of patient response to chemotherapy |
| WO2009132928A2 (en) * | 2008-05-02 | 2009-11-05 | Siemens Healthcare Diagnostics Gmbh | Molecular markers for cancer prognosis |
| EP2664679B1 (en) * | 2008-05-30 | 2017-11-08 | The University of North Carolina At Chapel Hill | Gene expression profiles to predict breast cancer outcomes |
| WO2010003771A1 (en) | 2008-06-16 | 2010-01-14 | Siemens Healthcare Diagnostics Gmbh | Molecular markers for cancer prognosis |
| WO2010003773A1 (en) * | 2008-06-16 | 2010-01-14 | Siemens Medical Solutions Diagnostics Gmbh | Algorithms for outcome prediction in patients with node-positive chemotherapy-treated breast cancer |
| EP2163649A1 (en) * | 2008-09-11 | 2010-03-17 | Fédération Nationale des Centres de Lutte Contre le Cancer | Molecular classifier for evaluating the risk of metastasic relapse in breast cancer |
| KR101161789B1 (ko) | 2008-12-10 | 2012-07-03 | 한국생명공학연구원 | 간암에 대한 신규 바이오마커 및 그의 용도 |
| WO2010076322A1 (en) * | 2008-12-30 | 2010-07-08 | Siemens Healthcare Diagnostics Inc. | Prediction of response to taxane/anthracycline-containing chemotherapy in breast cancer |
| US20120065084A1 (en) | 2009-04-17 | 2012-03-15 | Universite Libre De Bruxelles | Methods and tools for predicting the efficiency of anthracyclines in cancer |
| JP2012527631A (ja) | 2009-05-22 | 2012-11-08 | ザ・ユナイテッド・ステイツ・オブ・アメリカ・アズ・リプリゼンティド・バイ・ザ・セクレタリー・デパートメント・オブ・ヘルス・アンド・ヒューマン・サービシズ | タキサン型化学療法剤用のインジケータとしてのｓｅｒ４７３でのａｋｔリン酸化反応 |
| WO2011121028A1 (en) | 2010-03-30 | 2011-10-06 | Siemens Healthcare Diagnostics Inc. | Algorithm for prediction of benefit from addition of taxane to standard chemotherapy in patients with breast cancer |
| PT2553118E (pt) | 2010-03-31 | 2014-12-17 | Sividon Diagnostics Gmbh | Método para previsão da recorrência de cancro da mama em tratamento endócrino |
| US20130042333A1 (en) | 2011-05-06 | 2013-02-14 | Jean-Gabriel JUDDE | Markers for cancer prognosis and therapy and methods of use |
| ES2608322T3 (es) | 2011-07-28 | 2017-04-07 | Sividon Diagnostics Gmbh | Procedimiento para predecir la respuesta a la quimioterapia en un paciente que padece o está en riesgo de desarrollar cáncer de mama recurrente |
| EP2786140A4 (en) | 2011-11-28 | 2015-10-28 | Nat Res Council Canada | PACLITAXEL REACTION MARKERS FOR CANCER |
| WO2013188600A1 (en) | 2012-06-12 | 2013-12-19 | Washington University | Copy number aberration driven endocrine response gene signature |
| AU2015217698A1 (en) | 2014-02-12 | 2016-06-30 | Sividon Diagnostics Gmbh | Method for predicting the response and survival from chemotherapy in patients with breast cancer |
| CN106480201A (zh) | 2016-10-26 | 2017-03-08 | 北京鑫诺美迪基因检测技术有限公司 | 乳腺癌转移评估试剂盒 |
-
2011
- 2011-03-29 PT PT117105262T patent/PT2553118E/pt unknown
- 2011-03-29 EP EP11710526.2A patent/EP2553118B1/en active Active
- 2011-03-29 JP JP2013501812A patent/JP5940517B2/ja active Active
- 2011-03-29 EP EP14188791.9A patent/EP2845911B1/en not_active Not-in-force
- 2011-03-29 ES ES11710526.2T patent/ES2525382T3/es active Active
- 2011-03-29 CA CA2793133A patent/CA2793133C/en active Active
- 2011-03-29 WO PCT/EP2011/054855 patent/WO2011120984A1/en active Application Filing
- 2011-03-29 RU RU2012146343A patent/RU2654587C2/ru not_active IP Right Cessation
- 2011-03-29 PT PT141887919T patent/PT2845911T/pt unknown
- 2011-03-29 KR KR1020127025899A patent/KR101864855B1/ko active IP Right Grant
- 2011-03-29 UA UAA201212456A patent/UA110790C2/uk unknown
- 2011-03-29 PL PL11710526T patent/PL2553118T3/pl unknown
- 2011-03-29 HU HUE14188791A patent/HUE030164T2/en unknown
- 2011-03-29 ES ES14188791.9T patent/ES2587591T3/es active Active
- 2011-03-29 US US13/638,360 patent/US20130065786A1/en not_active Abandoned
- 2011-03-29 CN CN201610238134.6A patent/CN105821125A/zh active Pending
- 2011-03-29 BR BR112012024718A patent/BR112012024718A2/pt not_active IP Right Cessation
- 2011-03-29 PL PL14188791T patent/PL2845911T3/pl unknown
- 2011-03-29 BR BR122020016370-4A patent/BR122020016370B1/pt active IP Right Grant
- 2011-03-29 CN CN201180016811.5A patent/CN102971435B/zh active Active
- 2011-03-29 MX MX2012011167A patent/MX2012011167A/es active IP Right Grant
-
2012
- 2012-09-27 ZA ZA2012/07229A patent/ZA201207229B/en unknown
-
2013
- 2013-08-01 HK HK13108970.2A patent/HK1181817A1/xx unknown
-
2016
- 2016-05-18 JP JP2016099192A patent/JP2016189781A/ja not_active Abandoned
- 2016-08-11 US US15/234,828 patent/US10577661B2/en active Active
-
2020
- 2020-01-17 US US16/746,334 patent/US10851427B2/en active Active
- 2020-10-27 US US17/081,924 patent/US11913078B2/en active Active
-
2024
- 2024-01-11 US US18/410,966 patent/US20240229150A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1181817A1 (en) | Method for breast cancer recurrence prediction under endocrine treatment | |
| IL276362A (en) | Cancer treatment methods | |
| IL276488A (en) | A method for predicting the prognosis of breast cancer | |
| ZA201205003B (en) | Methods for treating breast cancer | |
| EP2558109A4 (en) | METHOD FOR TREATING HARD TUMORS | |
| ZA201208815B (en) | Methods of treating bladder cancer | |
| EP2643001A4 (en) | METHOD OF TREATING CANCER | |
| EP2635286A4 (en) | METHOD FOR THE TREATMENT OF CANCER | |
| HK1189272A1 (zh) | 治療癌症的方法 | |
| HRP20160851T1 (hr) | Prediktori za liječenje karcinoma | |
| EP2640383A4 (en) | METHOD OF TREATING BREAST CANCER AND OVARIAN CANCER | |
| EP2640390A4 (en) | METHODS OF TREATING CANCER | |
| EP2632459A4 (en) | METHOD OF TREATING NEUROENDOCRINE TUMORS | |
| EP2649225A4 (en) | BIOMARKERS FOR THE PREDICTION OF BREAST CANCER | |
| EP2560648A4 (en) | METHOD OF TREATING PANCREATIC CANCER | |
| PL2608802T3 (pl) | Immunoterapeutyczny sposób leczenia raka gruczołu krokowego | |
| EP2560639A4 (en) | METHOD FOR THE TREATMENT OF PROSTATE CANCER | |
| ZA201208905B (en) | Cancer therapy method | |
| EP2707011A4 (en) | METHOD FOR THE TREATMENT OF PROSTATE CANCER | |
| GB201005367D0 (en) | Prediction of prostate cancer recurrence time |